{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:12:02Z","timestamp":1791958322257,"version":"4.3.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/qco.0000000000000082","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T14:31:47Z","timestamp":1403620307000},"page":"316-321","source":"Crossref","is-referenced-by-count":21,"title":["Tuberculosis in solid organ transplant candidates and recipients"],"prefix":"10.1097","volume":"27","author":[{"given":"Aruna K.","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210205","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.00000712","article-title":"The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.","volume":"40","author":"Bumbacea","year":"2012","journal-title":"Eur Respir J"},{"key":"R2-4-20210205","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"R3-4-20210205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation.","volume":"13","author":"Subramanian","year":"2013","journal-title":"Am J Transplant"},{"key":"R4-4-20210205","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/cid\/cit488","article-title":"Challenging issues in tuberculosis in solid organ transplantation.","volume":"57","author":"Horne","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R5-4-20210205","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-6143.2011.03493.x","article-title":"An update on donor-derived disease transmission in organ transplantation.","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"R6-4-20210205","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/j.1600-6143.2012.04205.x","article-title":"Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report.","volume":"12","author":"Morris","year":"2012","journal-title":"Am J Transplant"},{"key":"R7-4-20210205","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/ajt.12344","article-title":"Donor-derived tuberculosis (TB) infection in lung transplant despite following recommended algorithm.","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"R8-4-20210205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/TP.0b013e3182977adf","article-title":"Incidence of tuberculosis in deceased-organ donors and transmission risk to recipients in Spain.","volume":"96","author":"Coll","year":"2013","journal-title":"Transplantation"},{"key":"R10-4-20210205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1164\/rccm.201209-1621CI","article-title":"IFN- release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults.","volume":"188","author":"Redelman-Sidi","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-4-20210205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"R12-4-20210205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3062.2011.00666.x","article-title":"Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study.","volume":"14","author":"Theodoropoulos","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"R13-4-20210205","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/lt.22375","article-title":"Comparison of the 2-step tuberculin skin test and the QuantiFERON-TB Gold In-Tube test for the screening of tuberculosis infection before liver transplantation.","volume":"17","author":"Casas","year":"2011","journal-title":"Liver Transpl"},{"key":"R14-4-20210205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2012.12.005","article-title":"Interferon- release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review.","volume":"66","author":"Munoz","year":"2013","journal-title":"J Infect"},{"key":"R15-4-20210205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s15010-012-0291-0","article-title":"Comparison of the tuberculin skin test and interferon- release assay for the diagnosis of latent tuberculosis infection before kidney transplantation.","volume":"41","author":"Kim","year":"2013","journal-title":"Infection"},{"key":"R16-4-20210205","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10156-013-0578-9","article-title":"Living donor and recipient screening for latent tuberculosis infection by tuberculin skin test and interferon-gamma releasing assay in a country with an intermediate burden of tuberculosis.","volume":"19","author":"Moon","year":"2013","journal-title":"J Infect Chemother"},{"key":"R17-4-20210205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon- release assays for incident active tuberculosis: a systematic review and meta-analysis.","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R18-4-20210205","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5588\/ijtld.11.0416","article-title":"Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA.","volume":"16","author":"Lange","year":"2012","journal-title":"Int J Tuberc Dis"},{"key":"R19-4-20210205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon- release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"R20-4-20210205","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A prospective longitudinal study evaluating the usefulness of a T-cell based assay for latent tuberculosis infection in kidney transplant recipients.","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transpl"},{"key":"R21-4-20210205","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1164\/rccm.201206-1134OC","article-title":"Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents.","volume":"186","author":"Machingaidze","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-4-20210205","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/01.tp.0000266578.45634.4f","article-title":"Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.","volume":"83","author":"Jahng","year":"2007","journal-title":"Transplantation"},{"key":"R23-4-20210205","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00007890-200209270-00029","article-title":"Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.","volume":"74","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"R24-4-20210205","first-page":"2406","article-title":"Is isoniazid safe for liver transplant candidates with latent tuberculosis Transplant P","volume":"44","author":"Stucchi","year":"2012","journal-title":"roc"},{"key":"R25-4-20210205","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/lt.23480","article-title":"Chemoprophylaxis with isoniazid in liver transplant recipients.","volume":"18","author":"Fabrega","year":"2012","journal-title":"Liver Transpl"},{"key":"R26-4-20210205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.23622","article-title":"Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.","volume":"19","author":"Hickey","year":"2013","journal-title":"Liver Transpl"},{"key":"R27-4-20210205","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/TP.0b013e3182a94a2f","article-title":"Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates.","volume":"97","author":"Lopez de Castilla","year":"2014","journal-title":"Transplantation"},{"key":"R28-4-20210205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1378\/chest.12-2294","article-title":"Recognizing laboratory cross-contamination: two false-positive cultures of Mycobacterium tuberculosis - Oklahoma, 2011.","volume":"144","author":"Johnson","year":"2013","journal-title":"Chest"},{"key":"R29-4-20210205","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1111\/tid.12048","article-title":"Tuberculosis hepatitis in renal transplant recipients following alemtuzumab induction therapy.","volume":"15","author":"Bosch","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R30-4-20210205","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.cgh.2012.10.042","article-title":"Atypical presentation of miliary tuberculosis with hepatic involvement early after renal transplantation.","volume":"11","author":"Musumba","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-4-20210205","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.transproceed.2012.09.060","article-title":"Clinical features and outcomes of tuberculosis in solid organ transplant recipients.","volume":"44","author":"Bodro","year":"2012","journal-title":"Transplant Proc"},{"key":"R32-4-20210205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/cid\/cir276","article-title":"Opportunistic infection-associated immune reconstitution syndrome in transplant recipients.","volume":"53","author":"Sun","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R33-4-20210205","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/TP.0b013e31828719c8","article-title":"Mycobacterium tuberculosis-associated immune reconstitution syndrome in solid organ transplant recipients.","volume":"95","author":"Sun","year":"2013","journal-title":"Transplantation"},{"key":"R34-4-20210205","doi-asserted-by":"crossref","first-page":"e81856","DOI":"10.1371\/journal.pone.0081856","article-title":"LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients.","volume":"8","author":"Goovaerts","year":"2013","journal-title":"PLoS One"},{"key":"R35-4-20210205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens.","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"R36-4-20210205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1473-3099(13)70034-3","article-title":"Tuberculosis biomarkers discovery: developments, needs and challenges.","volume":"13","author":"Wallis","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R37-4-20210205","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1128\/AAC.02658-13","article-title":"Novel regimens identified in mice for treatment of latent tuberculosis infection in contacts of multidrug-resistant tuberculosis cases.","volume":"58","author":"Lanoix","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-4-20210205","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S2213-2600(13)70234-0","article-title":"Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial.","volume":"2","author":"Skrahin","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R39-4-20210205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nm.3458","article-title":"Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.","volume":"20","author":"Lee","year":"2014","journal-title":"Nat Med"},{"key":"R40-4-20210205","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(13)62675-6","article-title":"Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.","volume":"383","author":"Pietersen","year":"2014","journal-title":"Lancet"},{"key":"R41-4-20210205","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S1053-2498(02)01189-0","article-title":"Multidrug-resistant tuberculosis in a lung transplant recipient.","volume":"22","author":"Lee","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R42-4-20210205","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1473-3099(13)70128-2","article-title":"Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study.","volume":"13","author":"Moonan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R44-4-20210205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cid\/cis849","article-title":"Sustainable tuberculosis drug development.","volume":"56","author":"Wallis","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QCO.0000000000000082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:05:40Z","timestamp":1620972340000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201408000-00004"}},"subtitle":["current and future challenges"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0000000000000082","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}